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Abstract
Background: Significant bacteriuria (SBU) and urinary tract infections (UTIs) are common in patients with spina
bifida and neuropathic detrusor sphincter dysfunction. Laboratory agar plated culture is the gold standard to
establish SBU. It has the disadvantage of diagnostic and subsequent therapeutic delay. Leukocyte esterase tests
(LETs) and dip slides proved to be useful in the general populations to exclude SBU and UTI. The aim of this study
was to evaluate the reliability of LET and dip slide in children with spina bifida without symptoms of UTI. The
reliability in children with asymptomatic SBU was not studied before.
Methods: In one hundred and twelve children with spina bifida on clean intermittent catheterization LETs and dip
slides were compared with laboratory cultures. Both tests and agar plated cultures were performed on catheterized
urine samples. The hypothesis was that the home tests are as accurate as laboratory cultures.
Results: A SBU was found in 45 (40%) of the 112 laboratory cultures. A negative LET excluded SBU (negative
predictive value 96%), while a positive LET had a positive predictive value of 72%. The false positive rate was 28%.
Dip slide determination of bacterial growth had no added value, other than serving as transport medium.
Conclusions: In spina bifida children, leukocyte esterase testing can be used to exclude significant bacteriuria at
home, while dip slide tests have no added value to diagnose or exclude significant bacteriuria.
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Background
Clean intermittent catheterization (CIC) and antibiotic
prophylaxis have reduced the incidence of parenchymal
kidney damage in children with spina bifida [1-3]. In
these patients, the main objective of any urinary diag-
nostic test is to detect or exclude urinary tract infections
(UTIs) to prevent under- and over-treatment. The diag-
nosis of UTI is made on clinical symptoms, leukocyturia
and significant bacteriuria (SBU). Several simple tests to
detect a UTI, such as dip slides and leukocyte esterase
tests (LET) were studied extensively. Two recent meta-
analyses showed that a LET had a negative predictive
value (NPV) of 90%, with a positive predictive value
(PPV) of 60% [4,5]. A UTI therefore has to be confirmed
with a urine culture [4], which takes at least three days,
and treatment is postponed. Dip slides with two or three
culture media were tested to diagnose SBU in primary
care [6-9]. As PPV was poor, it was concluded that the
use of dip slide urine cultures should only be used to ex-
clude SBU.
The aim of the present study was to evaluate the reli-
ability of the LET and dip slide in children with spina
bifida. Children with clinical symptoms of UTI partici-
pated in a parallel study, and were not included in this
study [10]. Only children with asymptomatic SBU were
included. We also assessed whether general patient char-
acteristics, such as sex, age and use of prophylactic anti-
biotics can predict asymptomatic SBU. The hypothesis
was that LET and UricultW Duo dip slide are as accurate
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as laboratory cultures in determining significant
bacteriuria.
Patients and methods
One hundred and twelve patients with spina bifida on
CIC known at the Gasthuisberg University Hospital Leu-
ven, Belgium participated in the study. Patients catheter-
ized themselves or were catheterized by their parents or
primary care takers for a fresh urine sample at the quar-
terly control visit. Patients who had completed treatment
for UTI less than 4 weeks before the visit to the clinic,
or who had febrile episodes immediately preceding the
visit, or a clinical suspicion for a UTI at the visit were
excluded. A leukocyte esterase test (LET, Combur-2W
test strip, Roche, Switzerland) was performed on the
urine sample, regarded “positive” in every range of dis-
coloration. The sample was also inoculated onto a dip
slide (UricultW Duo, Orion Diagnostics, Finland), which
contains an aselective cystine-lactose-electrolyte defi-
cient (CLED) agar for Gram-positive bacteria and entero-
bacteriaceae, and MacConkey agar for non-glucose
fermenting Gram-negative rods. The dip slide was incu-
bated in a bottle warmer (PhilipsW SBC 215/00, Philips
SA, Belgium) at 36.3 ± 2.5 °C, as measured over 48
hours with a calibrated DicksonW SK 180 temperature
logger (Dickson Corporation, Addison, USA). After 24
hours in the bottle warmer, the dip slide was evaluated
for colony forming units by a trained research nurse,
and the result was reported as ‘no growth’ or ‘growth’
(visible colonies). The same urine sample was also sent
for ‘gold standard’ agar plated culture. SBU was defined
as a colony count of ≥104 per milliliter of one single spe-
cies in a catheterized sample. Of patients with multiple
samples, only the first was used for analysis. To establish
whether general patient characteristics could dis-
criminate SBU from no SBU, logistic regression was
used with gold standard outcome (positive / negative) as
dependent variable and age and sex as independent vari-
ables. This model was then extended with prophylaxis
(model 2), LET testing (model 3), and dip slide testing
(model 4). Model results are expressed as odds ratios
(95% confidence intervals, and p-values). Discriminative
capacity for these four models was evaluated using areas
under the Receiver Operator Characteristic (ROC)
curves (AUC). This study is approved by the ethics com-
mittee from the Leuven University Hospital, and per-
formed after parental or guardian consent.
Results
Of the 112 asymptomatic patients, 45 had a positive agar
plated culture, hence the prior probability for SBU was
40%, which is consistent with previous studies. The
patients had an age range of 0 to 35 years (median 13.0,
long-term spina bifida follow-up patients over 18 years
of age are included). Fifty (45%) were boys and 61 (68%)
were on antibiotic prophylaxis. Table 1 shows the results
of four consecutive models predicting the gold standard
culture outcome. The LET had the strongest discrimina-
tive power, while dip slide testing did not add signifi-
cantly. In Figure 1, the discriminative capacity of the
models is shown graphically as ROC curves for age and
sex (AUC = 0.64, p = 0.01); age, sex and prophylaxis
(AUC = 0.76, p = 0.003); age, sex, prophylaxis and LET
(AUC = 0.91, p < 0.0001) and age, sex, prophylaxis, LET
and dip slide (AUC = 0.91, p < 0.0001). As this study
addressed the role of LET and dip slide to rule out SBU
in spina bifida patients without complaints of UTI, we
proceeded with these tests only, as shown in Table 2.
Given an a-priori chance of SBU of 40%, a positive LET
had a PPV of 72%, while a negative LET substantially
decreased the chance of a SBU to 4% (NPV = 96%). Dip
slide testing had a similar PPV (73% versus 72% for
LET) but substantially lower NPV (78% versus 96%
for LET). Combining LET with dip slide improved
neither PPV (positive LET 72% versus both LET and
dip slide positive 74%) nor NPV (negative LET 96% ver-
sus both LET and dip slide negative 98%). Pathogens
found were Escherichae coli (N=26), Klebsiella pneumo-
nia (4), Streptococcus species (4), Enterococcus species
(3), Proteus mirabilis (3), Pseudomonas aeruginosa
(2), Serratia marcescens (1), Staphylococcus aureus (1)
and Providencia rettgeri (1). In three of the 45 posi-
tive cultures (one Streptococcus, one Staphylococcus
and one Enterococcus species) the LET was negative,
resulting in 93.3% sensitivity. There were 16 false
positive LETs in 67 negative cultures, resulting in 76%
specificity.
Table 1 Determinants of significant bacteriuria
Model Odds ratio 95% CI p-value
1 Sex (male vs female) 1.9 0.9 - 4.2 0.10
Age (yrs) 1.06 1.01 - 1.12 0.03
2 Sex (male vs female) 1.8 0.8 - 4.1 0.13
Age (yrs) 1.07 1.01 - 1.14 0.02
Prophylaxis (yes/no) 0.5 0.2 - 1.0 0.06
3 Sex (male vs female) 4.1 1.2 - 14.4 0.03
Age (yrs) 1.03 0.94 - 1.12 0.54
Prophylaxis (yes/no) 0.3 0.1 - 1.1 0.07
LET 101 18 - 583 <0.0001
4 Sex (male vs female) 3.8 1.07 - 13.4 0.04
Age (yrs) 1.03 0.95 - 1.13 0.46
Prophylaxis (yes/no) 0.3 0.1 - 1.1 0.07
LET 75 11 - 495 <0.0001
Dipslide 1.6 0.5 - 5.4 0.46
LET = leukocyte esterase test.
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Discussion
In this study of 112 spina bifida patients on clean inter-
mittent catheterization, a negative LET excludes SBU in
a home setting with a NPV of 96%. A negative dip slide
alone was not effective to rule out SBU, and a negative
LET together with a negative dip slide did not improve
NPV. Both a positive LET and dip slide had a false posi-
tive rate of more than 20 percent compared to labora-
tory cultures, and cannot be used to diagnose SBU.
Leukocyte esterase test
Our results are consistent with other studies and meta-
analyses, performed in the general pediatric populations
[4,5,11-15]. Anderson et al. studied the LET in children
with neurogenic bladders, combined with nitrite test,
with comparable results [16]. Adversely, in a similar
study population, Liptak et al. found a lower NPV (83%)
[17]. A significantly lower NPV for the LET (68%)
was also seen in adults with spinal cord injury, which
could be attributed to their lower threshold to diag-
nose SBU, with 102 colony forming units per milliliter
of catheterized urine. In this study, the threshold was
104 cfu/ml [18].
In this study, boys had a significantly higher risk of
SBU than girls. In a study by Seki et al., girls with myelo-
dysplasia were more likely to get colonized with bacteria
[19]. Age did not influence the risk for SBU in our popu-
lation, in accordance with previous studies [20]. Prophy-
lactic antibiotics tended to reduce the risk of SBU, as
was shown in previous studies both in the general
Figure 1 ROC curves of age, sex, Combur LET and Uricult dipslide.
Table 2 Predictive value of (combinations of) Leukocyte Esterase Test and dipslide for significant bacteriuria
Tests Gold
standard
Positive Negative Total PPV in % (95% CI) NPV in % (95% CI)
LET Positive 43 17 60 72 (50 – 83)
Negative 2 50 52 96 (85 – 99)
Dipslide Positive 29 11 40 73 (56 – 85)
Negative 16 56 72 78 (66 – 87)
Combi Both positive 28 10 38 74 (57 – 87)
Not both positive 17 57 74 77 (66 – 86)
Combi Not both negative 44 18 62 71 (58 – 82)
Both negative 1 49 50 98 (89 – 99)
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population [21-23] and in patients with spina bifida
[22,24,25]. Compared to the LET however, age, sex and
the use of antibiotic prophylaxis are less reliable to pre-
dict SBU in children with spina bifida.
Dip slides
In this study, a negative dip slide with a NPV of 78%
and a false negative rate of 22% could not rule out SBU.
With a PPV of 73%, and a false positive rate of 27%,
SBU cannot be diagnosed with a dip slide. In a recent
study in 200 children with UTI symptoms and a positive
LET, UricultW Trio dip slides incubated in a laboratory
incubator were compared with colony counts on blood
agar plates. The sensitivity of 68%, and a false negative
rate of 29% was comparable to this study [26]. Two
mayor pitfalls were found: the small pin-point colonies
of some Enterococci and most Streptococci on the CLED
medium were mistaken for no growth, and transparent
E. coli colonies are almost invisible. The untrained eye
can be aided by the European Urinalysis Guidelines [27].
Inspection of the dip slide with a 12× magnifying glass,
and comparing the incubated media with those of an un-
used dip slide. When growth of E coli, Enterococci, and
Streptococci on the 14 false negative UricultW Duo dip
slides was identified in this study, the false negatives
would have decreased from 27% to 14%.
This study included only asymptomatic patients, and
although the bacteriuria is significant, this has no clinical
consequences such as therapeutic antibiotic administra-
tion. Compared to asymptomatic SBU, in clinical UTI
leukocyturia is obligatory, most likely increasing both
NPV and PPV of the LET, emphasizing the value of the
LET. A further study to evaluate the reliability of the dip
slide in children with spina bifida and clinical symptoms
of UTI is recommended.
Conclusion
In home testing of spina bifida children on clean inter-
mittent catheterization, leukocyte esterase testing can be
used to exclude significant bacteriuria. Both leukocyte
esterase test and dip slide are not sensitive enough to
predict significant bacterial growth, and a agar plated
culture should therefore be performed when either test
is positive. Other than serving as transport medium, dip
slide testing has no added to diagnose or exclude signifi-
cant bacteriuria.
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